Wave Neuroscience

06/26/2026

PTSD Awareness Month is an opportunity to recognize the millions of individuals, families, and veterans whose lives are impacted by trauma. Awareness starts the conversation—but innovation changes what's possible.
After years of research, clinical validation, and rigorous FDA review, Wave Neuroscience is proud to announce that the MeRT® System is now FDA cleared for the treatment of PTSD. This milestone represents the first FDA-cleared, non-pharmacological, non-invasive, biomarker-guided, personalized treatment for PTSD.
While raising awareness remains essential, advancing scientifically and clinically validated treatments has the potential to transform lives and create better futures.

Creating personalized Braincare™ technologies that help you care for your most vital organ. 🧠

06/17/2026

To date, there have been few FDA-cleared treatment options for PTSD, leaving a significant unmet need.

Today, that begins to change.

The FDA clearance of the MeRT® System for PTSD marks a defining moment in the advancement of brain-based mental healthcare, bringing EEG-guided, personalized neuromodulation into a new era for individuals living with PTSD.

This milestone represents years of research, dedication to following the data, and a belief that the future of mental healthcare can be more objective, biologically informed, and timely.

If you or someone you love is struggling with PTSD, now is the time to learn what the FDA cleared MeRT System may do for you.

Explore the science. Find a provider. Learn more about MeRT at waveneuro.com

03/18/2026

During Brain Awareness Week, we’re proud to be part of a broader scientific and clinical community working to deepen our understanding of brain function.
As research continues to evolve, new tools and approaches are helping bring greater clarity to the patterns and dynamics that shape how the brain operates. Progress in this field is driven by a shared commitment to expanding knowledge and supporting more informed perspectives on brain health.